A. E. Canda Et Al. , "In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens.," Pleura and peritoneum , vol.9, no.1, pp.23-29, 2024
Canda, A. E. Et Al. 2024. In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens.. Pleura and peritoneum , vol.9, no.1 , 23-29.
Canda, A. E., Sever, T., Calibasi Kocal, G., Basbinar, Y., & Ellidokuz, H., (2024). In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens.. Pleura and peritoneum , vol.9, no.1, 23-29.
Canda, Aras Et Al. "In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens.," Pleura and peritoneum , vol.9, no.1, 23-29, 2024
Canda, Aras E. Et Al. "In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens.." Pleura and peritoneum , vol.9, no.1, pp.23-29, 2024
Canda, A. E. Et Al. (2024) . "In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens.." Pleura and peritoneum , vol.9, no.1, pp.23-29.
@article{article, author={Aras Emre Canda Et Al. }, title={In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens.}, journal={Pleura and peritoneum}, year=2024, pages={23-29} }